Stephanie M Ford1, Matthew T McPheeters2, Yves T Wang3, Pei Ma3, Shi Gu3, James Strainic4, Christopher Snyder4, Andrew M Rollins3, Michiko Watanabe2, Michael W Jenkins2. 1. Rainbow Babies and Children's Hospital Division of Neonatology, University Hospitals, Cleveland, Ohio, USA. 2. Department of Pediatric Cardiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. 3. Case Western Reserve University Department of Biomedical Engineering, Cleveland, Ohio, USA. 4. Rainbow Babies and Children's Hospital Division of Pediatric Cardiology, University Hospitals, Cleveland, Ohio, USA.
Abstract
BACKGROUND: The relationship between changes in endocardial cushion and resultant congenital heart diseases (CHD) has yet to be established. It has been shown that increased regurgitant flow early in embryonic heart development leads to endocardial cushion defects, but it remains unclear how abnormal endocardial cushions during the looping stages might affect the fully septated heart. The goal of this study was to reproducibly alter blood flow in vivo and then quantify the resultant effects on morphology of endocardial cushions in the looping heart and on CHDs in the septated heart. METHODS: Optical pacing was applied to create regurgitant flow in embryonic hearts, and optical coherence tomography (OCT) was utilized to quantify regurgitation and morphology. Embryonic quail hearts were optically paced at 3 Hz (180 bpm, well above intrinsic rate 60-110 bpm) at stage 13 of development (3-4 weeks human) for 5 min. Pacing fatigued the heart and led to at least 1 h of increased regurgitant flow. Resultant morphological changes were quantified with OCT imaging at stage 19 (cardiac looping-4-5 weeks human) or stage 35 (4 chambered heart-8 weeks human). RESULTS: All paced embryos imaged at stage 19 displayed structural changes in cardiac cushions. The amount of regurgitant flow immediately after pacing was inversely correlated with cardiac cushion size 24-h post pacing (P value < .01). The embryos with the most regurgitant flow and smallest cushions after pacing had a decreased survival rate at 8 days (P < .05), indicating that those most severe endocardial cushion defects were lethal. Of the embryos that survived to stage 35, 17/18 exhibited CHDs including valve defects, ventricular septal defects, hypoplastic ventricles, and common AV canal. CONCLUSION: The data illustrate a strong inverse relationship in which regurgitant flow precedes abnormal and smaller cardiac cushions, resulting in the development of CHDs.
BACKGROUND: The relationship between changes in endocardial cushion and resultant congenital heart diseases (CHD) has yet to be established. It has been shown that increased regurgitant flow early in embryonic heart development leads to endocardial cushion defects, but it remains unclear how abnormal endocardial cushions during the looping stages might affect the fully septated heart. The goal of this study was to reproducibly alter blood flow in vivo and then quantify the resultant effects on morphology of endocardial cushions in the looping heart and on CHDs in the septated heart. METHODS: Optical pacing was applied to create regurgitant flow in embryonic hearts, and optical coherence tomography (OCT) was utilized to quantify regurgitation and morphology. Embryonic quail hearts were optically paced at 3 Hz (180 bpm, well above intrinsic rate 60-110 bpm) at stage 13 of development (3-4 weeks human) for 5 min. Pacing fatigued the heart and led to at least 1 h of increased regurgitant flow. Resultant morphological changes were quantified with OCT imaging at stage 19 (cardiac looping-4-5 weeks human) or stage 35 (4 chambered heart-8 weeks human). RESULTS: All paced embryos imaged at stage 19 displayed structural changes in cardiac cushions. The amount of regurgitant flow immediately after pacing was inversely correlated with cardiac cushion size 24-h post pacing (P value < .01). The embryos with the most regurgitant flow and smallest cushions after pacing had a decreased survival rate at 8 days (P < .05), indicating that those most severe endocardial cushion defects were lethal. Of the embryos that survived to stage 35, 17/18 exhibited CHDs including valve defects, ventricular septal defects, hypoplastic ventricles, and common AV canal. CONCLUSION: The data illustrate a strong inverse relationship in which regurgitant flow precedes abnormal and smaller cardiac cushions, resulting in the development of CHDs.
Authors: Jennifer L Lucitti; Richard Visconti; Jacqueline Novak; Bradley B Keller Journal: Am J Physiol Heart Circ Physiol Date: 2006-04-28 Impact factor: 4.733
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-02-23 Impact factor: 29.690
Authors: Yves T Wang; Shi Gu; Pei Ma; Michiko Watanabe; Andrew M Rollins; Michael W Jenkins Journal: Biomed Opt Express Date: 2014-02-28 Impact factor: 3.732
Authors: Duncan B Sparrow; Gavin Chapman; Allanceson J Smith; Muhammad Z Mattar; Joelene A Major; Victoria C O'Reilly; Yumiko Saga; Elaine H Zackai; John P Dormans; Benjamin A Alman; Lesley McGregor; Ryoichiro Kageyama; Kenro Kusumi; Sally L Dunwoodie Journal: Cell Date: 2012-04-05 Impact factor: 41.582
Authors: Jamie Wikenheiser; Julie A Wolfram; Madhusudhana Gargesha; Ke Yang; Ganga Karunamuni; David L Wilson; Gregg L Semenza; Faton Agani; Steven A Fisher; Nicole Ward; Michiko Watanabe Journal: Dev Dyn Date: 2009-10 Impact factor: 3.780
Authors: Mary Ella Pierpont; Craig T Basson; D Woodrow Benson; Bruce D Gelb; Therese M Giglia; Elizabeth Goldmuntz; Glenn McGee; Craig A Sable; Deepak Srivastava; Catherine L Webb Journal: Circulation Date: 2007-05-22 Impact factor: 29.690
Authors: Lindsy M Peterson; Shi Gu; Ganga Karunamuni; Michael W Jenkins; Michiko Watanabe; Andrew M Rollins Journal: Biomed Opt Express Date: 2017-02-24 Impact factor: 3.732
Authors: Vinal Menon; John F Eberth; Lorain Junor; Alexander J Potts; Marwa Belhaj; Donald J Dipette; Michael W Jenkins; Jay D Potts Journal: Dev Dyn Date: 2017-10-04 Impact factor: 3.780
Authors: Sahar Elahi; Brecken J Blackburn; Maryse Lapierre-Landry; Shi Gu; Andrew M Rollins; Michael W Jenkins Journal: Biomed Opt Express Date: 2020-08-27 Impact factor: 3.732
Authors: Matthew T McPheeters; Yves T Wang; Andreas A Werdich; Michael W Jenkins; Kenneth R Laurita Journal: PLoS One Date: 2017-08-24 Impact factor: 3.240
Authors: Safdar Jawaid; James P Strainic; Jun Kim; Matthew R Ford; Lars Thrane; Ganga H Karunamuni; Megan M Sheehan; Amrin Chowdhury; Caitlyn A Gillespie; Andrew M Rollins; Michael W Jenkins; Michiko Watanabe; Stephanie M Ford Journal: Alcohol Clin Exp Res Date: 2021-01-02 Impact factor: 3.455
Authors: Shan Ling; Michael W Jenkins; Michiko Watanabe; Stephanie M Ford; Andrew M Rollins Journal: Am J Physiol Heart Circ Physiol Date: 2021-06-18 Impact factor: 5.125